Qube Research & Technologies (QRT)
GPCR icon

Qube Research & Technologies (QRT)’s Structure Therapeutics GPCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Buy
+73,599
New +$5.04M ﹤0.01% 1838
2024
Q2 		– Sell
-7,165
Closed -$307K – 4156
2024
Q1 		$307K Sell
7,165
-33,511
-82% -$1.41M ﹤0.01% 2796
2023
Q4 		$1.66M Buy
+40,676
New +$2.33M ﹤0.01% 1632

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GPCR Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 73,599 shares worth $3.55M. The stake represents ﹤0.01% of the portfolio and ranks #1838 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in GPCR as recently as Q1 2024.

Qube Research & Technologies (QRT) first reported a position in GPCR in Q4 2023 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Qube Research & Technologies (QRT) held 73,599 shares of Structure Therapeutics worth $3.55M as of Q1 2026.
  • Structure Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Structure Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1838 holding.
  • Qube Research & Technologies (QRT) first reported a position in Structure Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.